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ABSTRACT 
 
Design and Evaluation of Oligonucleotide Microarrays for  
 
the Detection of Bovine Pathogens 
 
 
by 
 
 
Ryan W. Black, Master of Science 
 
Utah State University, 2009 
 
 
Major Professor: Dr. Lee Rickords 
Department: Animal, Dairy and Veterinary Sciences 
 
 
Two microarray designs were developed and produced to screen for multiple 
bovine pathogens commonly found in the cattle industry today.  The first microarray was 
designed, built, and processed in-house using conventional material and equipment and 
targeted Pasteurella multocida, Manheimia haemolytica, Histophilus somni, and 
Arcanobacterium pyogenes.  For each pathogen, 12 perfect-match oligonucleotide 
probes, which were also designed in-house, targeted different sections of the respective 
16S ribosomal genes, and were coupled with 12 corresponding mismatched probes for 
background.  These arrays were able to produce distinct hybridization patterns for each 
pathogen that were easily visible without the need for computer analysis.  However, the 
need for PCR amplification of the 16S gene prior to hybridization motivated us to explore 
more efficient array options. The second designed microarray, a custom Affymetrix 
GeneChip, targeted Escherichia coli, Salmonella typhimurium, and Salmonella dublin in 
addition to the previously mentioned pathogens and was more successful in overall 
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performance than the “in-house” arrays.  In addition to the 16S gene, oligonucleotide 
probes targeted other genes (from 2 to >4500, depending on whether the genome was 
sequenced) that were unique to each pathogen.  This array also differed from the “in-
house” arrays in that mismatched probes were not designed.  The different probe sets 
performed at different detection limits as P. multocida, A. pyogenes, S. typhimurium, and 
S. dublin were detected with as little as 250ng of hybridized genomic DNA (gDNA), 
while M. haemolytica, H. somni, and E. coli required as much as 1µg gDNA.  These 
pathogens were also spiked into bovine tissue to simulate multiorgan infections in which 
they were individually detected with the microarray design. 
                                                                                                                   (76 pages) 
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CHAPTER I  
LITERATURE REVIEW 
 
Introduction 
 
 A variety of diagnostic techniques are available to both ranchers and veterinarians 
for the identification of bovine pathogens.  Observing clinical symptoms of a disease 
such as fever, diarrhea, congestion, and upper respiratory symptoms is often sufficient in 
making tentative diagnoses.  Abnormal behavior, such as depression, lethargy, instability 
or incoordination can also be the manifestations of various infections.  Gross lesions such 
as hemorrhage, infiltrates, abscesses, scar tissue, and excessive fluid in body cavities, 
may also be discernible internally in affected animals.1,2,12,44,71 
 Diagnosis of disease using clinical observations requires experience and historical 
knowledge of herds and individuals within a herd, since symptoms of various diseases 
can be similar.  However, definitive diagnostics are needed to confirm a clinical 
diagnosis.  Veterinary diagnostic laboratories focus on identifying pathogens that cause 
disease using techniques that include bacterial culture, biochemical testing, serological 
testing, and molecular diagnostic techniques.  Microbiological testing allows a 
veterinarian to identify specific bacteria based on colony characteristics, biochemical 
profiles and staining characteristics.  Serologic evaluation, Enzyme-Linked 
ImmunoSorbent Assay (ELISA), serum neutralization (SN), and other techniques are also 
used to identify specific antibodies or antigens found within the bloodstream or tissues to 
confirm the presence of or recent exposure to particular pathogens.1  Additional target 
factors include specific enzymes, microorganisms or certain components thereof, or 
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particles that agglutinate when mixed with specific antiserums.48,65  Molecular 
techniques, such as polymerase chain reaction (PCR), can identify pathogens by 
amplification of genetic material of the agent, often targeting specific genes that are 
unique to an organism.  Researchers continue to make improvements on these techniques 
with the goal of making the tests more accurate, more efficient, less complicated, and 
most importantly (at least to ranchers), less expensive.  A relatively new technology, the 
microarray, used primarily for gene expression analysis of biological systems, is recently 
and increasingly finding use as a detection tool for the identification of bacterial and viral 
genomes within infected tissue and ecological environmental samples.40  In this report, 
microarray technology is used to specifically identify pathogens associated with a 
number of mixed infections that are common to the cattle industry. 
 
Disadvantages of Current Techniques Used to Diagnose Bovine Diseases 
 
The primary methods that veterinary diagnostic laboratories use to diagnose a 
disease, other than clinical observations, include microbiology, biochemical tests, 
serological tests, histopathology, and molecular diagnostic techniques.  For many 
diseases, isolation of the infection-causing pathogens is the most direct method of 
confirming a diagnosis.  Materials used for bacterial culture are cost-effective.  However, 
isolating a pathogen from a mixed culture can be difficult and very time consuming, 
taking anywhere from days to months to cultivate sufficient colonies27 for definitive 
diagnosis.  Moreover, culture conditions are not known for every pathogen.  Finally, 
culturing zoonotic pathogens poses potential health risks to personnel and requires 
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Biological Safety Level (BSL) facilities, proper equipment, training and protocols to 
ensure the safety of those handling the pathogens.15   
 Biochemical and serological tests are designed to be more species and pathogen 
specific and techniques will vary depending on the type of pathogens involved.  The 
application of specific techniques requires some level of foreknowledge as to the identity 
of the suspected pathogen, since each test is species and pathogen specific.  Individually, 
these tests may be inexpensive, however, due to the method of testing (serum 
neutralization assays),44 multiple tests could be required for confirmation of a disease 
which would result in higher labor and material costs.  
Molecular techniques, like PCR, have made great strides in providing a cost 
efficient, fast, and safe means for diagnosing pathogens present in samples.  However, 
culture is still sometimes necessary, and many pathogens require different experimental 
conditions and optimized protocols and reagents, which again requires some suspicion as 
to the identity of the pathogen. 
Microarrays, another molecular technique, provide a means of potentially creating 
an all-in-one diagnostic assay which provides the ability to screen for multiple pathogens 
which is often seen in cases of co-infection or identify individual pathogens that present 
with similar clinical symptoms.  Also, all microarray experiments can be run using the 
same repeatable techniques and experimental conditions.  A limitation to many 
microarray detection assays is the requirement of PCR amplification of the target 
sequences prior to hybridization.73  Without this amplification, detection is often limited.  
This limitation creates a challenge when designing a microarray assay that is not species-
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specific.  This limitation is usually overcome through the use of non-specific universal 
primers.  
Unfortunately, microarray technology is currently associated with high cost.  
However, since multiple conventional tests are sometimes required to correctly identify 
all pathogens in a disease syndrome,1 the cost of multiple tests could easily be more 
expensive than the cost of a single microarray test.  Ultimately, a single microarray could 
provide diagnostic answers in a time-efficient and cost-effective manner compared to 
potential multiple diagnostic tests that could otherwise be required.     
 
Microarrays 
 
 Microarray assays are relatively new technology that is finding rapid approval and 
widespread application.  Microarrays are flat solid surfaces, usually glass, that contain 
numerous sequences of nucleotides (probes) that are physically and systematically bound 
perpendicularly to the surface in known locations.  These probes, varying in length from 
as small as 18 bases to hundreds of bases long, represent known regions of a genome, and 
usually correspond to specific genes.  Samples of either DNA or ribonucleic acids (RNA) 
are isolated from biological samples and labeled enzymatically with a fluorescent 
molecular tag and, in this report, termed as “target.”  The labeled target is hybridized to 
the array by binding the target DNA/RNA to a complimentary probe sequence via base-
pair binding.  Fluorescent molecular tags can then be quantitatively measured at each 
probe location to determine the relative amount of each target sequence present in an 
extracted DNA/RNA sample.  The power of microarray technology is the ability to 
analyze tens of thousands of genes (or gene sequences) simultaneously in a single 
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experiment.23,47   The primary function of microarray technology is for gene expression 
profiling, but other applications include identification of potential drug targets, detection 
of mutations or single nucleotide polymorphisms, detection of short tandom repeats, 
detection of sequence insertions and deletions, comparative genomic hybridization, and 
the identification of genomes or parts of genomes (ie. bacterial, viral).32 
 
History of Microarray Technology 
 
 In the late 1970s, the first parallel hybridization analysis experiments, known as 
the dot blots, were introduced43 to the scientific world by taking advantage of an earlier 
idea to use multiple DNA libraries arrayed on filters to cross-correlate cloned 
sequences.68  Creating these dot blots was a manual procedure that was improved in the 
early 1990s by using robotics to spot probes on filter surfaces which allowed greater 
spotting density, accuracy, and speed, while at the same time reducing human error.36  
Microarrays became more defined as further improvements were introduced in robotic 
spotting technique, and in spotting material, such as glass, polypropylene, nylon, and 
silicon, that enabled an increase in production, spotting density, and in some cases, cost-
effectiveness.68  Microarrays were generally produced in-house for much of the 1990s, 
but some laboratories were able to commercialize their specialized version of the 
microarray.  In 1996, Affymetrix (Santa Clara, California, USA) began to mass-produce 
and commercialize their microarray platform, called the GeneChip.  Instead of spotting 
nucleotides, however, they introduced a new technique by synthesizing short 
oligonucleotides directly onto a glass surface using proprietary photolithographic 
techniques.50  Other major companies followed with their own designs.  For example, 
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Agilent Technologies (Santa Clara, California, USA) builds longer oligonucleotides on a 
glass slide using inkjet printing technology and phosphoramidite chemistry.38  Over the 
years, there has been a decrease in the production of in-house spotted arrays as scientists 
refer to more reliable and consistent commercial arrays, though research labs still 
commonly produce in-house arrays in an attempt to keep expenses down.   
 
Different Microarray Platforms 
 
 As microarray technology has developed, different strategies for microarray 
design have emerged from both academic and commercial groups.  Many of the 
“homemade” in-house spotted arrays initially employed long cloned cDNA samples as 
probes, each of which most often represented an entire gene.66  However, the use of 
cDNA clones as probes have diminished due to concerns about annotation, clone identity, 
and probe performance.  The use of oligonucleotides as probes has found greater 
popularity, especially among commercial platforms, as these probes have shown better 
hybridization characteristics and companies have been able to provide reliable libraries 
containing the annotation and identity of the oligonucleotides.77   
 Currently, most array platforms utilize either a one-color or two-color dye system.  
The spotted cDNA arrays regularly use the two-color dye system, in which two samples, 
each labeled with different fluorescent tags such as cyanine-3 (Cy3) and cyanine-5 (Cy5), 
are hybridized to a single array.66  Hybridizing two samples, a control and a treatment, to 
one array provides an advantage by removing array-to-array variability that would 
otherwise need to be dealt with when comparing two samples on two arrays.  A third 
fluorescent dye (fluorescein) can also be used to help monitor quality control measures 
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with prehybridization variables.33,34 
Affymetrix GeneChips are a one-color platform in which a single sample is 
hybridized to a single array.  These GeneChips are built with a series of short 25-mer 
oligonucleotide probes that represent the genes within a genome.  These oligonucleotides 
have a greater performance over the much longer cDNA probes, but multiple probes 
grouped in a probe set (which usually represents one gene) are required to overcome the 
lack of specificity of a 25-mer sequence and increase the overall confidence level.  These 
probe sets usually contain between 11-20 probes per probe set.  Thus, the GeneChips 
exhibit a much higher density, up to 1,000,000 probes/cm2,6 even though the human 
genome only contains 30,000 genes.  Array-to-array variability is reduced through 
carefully controlled array production and hybridization methods.6   
 Agilent Technologies has more recently produced its own line of oligonucleotide 
microarrays that use the two-color platform.  The Agilent arrays carry longer 60-mer 
oligonucleotide probes, which they claim allow for higher specificity compared to the 
smaller (Affymetrix GeneChip) probes.38  Also, their arrays, which can contain as many 
as 44,000 features, do not require as high a density coverage as the GeneChips.  Longer 
probes inkjet technology allow for a more cost-effective production of commercial 
microarrays.  
 In one study comparing the performance of three commercial microarrays, 
Affymetrix Genechips (short oligonucleotides, one-color platform), GE Healthcare 
CodeLink Microarrays (Tempe, Arizona, USA) (long oligonucleotides, one-color 
platform), and Agilent microarrays (long oligonucleotides, two-color platform)), it was 
reported that there was a higher level of reproducibility from one-color based arrays 
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(Affymetrix GeneChips and GE Healthcare CodeLink Microarrays) compared to the two-
colored Agilent platform.  Furthermore, Affymetrix had higher overall concordance with 
same-sample qPCR results.20  Despite this single study, there seems to be no clear 
consensus as to which platform performs the best or whether the different platforms are 
even comparable.  Various studies claim major differences in the data produced,46,64,69 
while others insist that there is ample levels of concordance among the different 
platforms.39,79   
 
Microarray Applications in Human and Animal Diagnostics 
 
 Microarray technology has been applied in both human and animal health studies.  
For example, microarrays have been used to profile the expression of genes at different 
stages of cancer,22,31,41,67 profile gene expression of neurological diseases such as 
Alzheimer’s disease,4,18,21,35 and identify infectious diseases.13,16,59  Additional uses of 
microarray technology in human studies include drug discovery, pharmacogenomics, and 
toxicogenomics studies,10,19,76 as well as identifying hypothetical genes that might trigger 
health-related issues, like obesity, alcoholism, and drug addiction.24  
Microarrays have been used more in human related clinical applications than 
animal studies.  Nevertheless, microarrays have played a significant role in profiling the 
gene expression patterns of animal diseases, usually only as starting points for data 
mining, to be followed later by more specific tests.  Beyond gene expression experiments, 
the most common use of microarrays in animal health has been in the detection and 
genotyping of animal pathogens.8,9,11,60,72  A less widely used application is direct-
mutation screening for single-gene diseases in dogs, horses, and some livestock.55  In all 
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these applications, continued development of genomic maps of individual species will 
provide the resources necessary to further animal health studies in the future60 and may 
even allow microarray technology to assist in breeding decisions.25   
 
Hybridization and Washing 
 
Hybridization is the formation of heteroduplex molecules when a target and probe 
bind together.  Under perfect conditions, the target will only hybridize to a probe that is 
perfectly complimentary.  Therefore, it is possible to determine the sequence of a target, 
since the probe has known sequence information and a known location, both on the array 
and within a genome.  However, microarray experiments are anything but perfect.  There 
are various conditions that will affect hybridization efficiency.  These conditions include 
hybridization temperatures, the concentration of monovalent cations such as sodium, the 
respective concentrations of the target and probe, GC content, and buffer content.   
Optimal hybridization temperature is generally lower than the calculated melting 
temperature of the probe sequence.  However, while the melting temperature can give an 
estimate, optimal hybridization temperature must be experimentally determined.  A lower 
temperature will result in an increase of non-specific binding, while a higher temperature 
will reduce true signal.   
 All nucleotide molecules are composed of a negatively charged phosphate 
backbone, which can impede heteroduplex formation.  To negate this hindrance, 
monovalent cations, such as sodium, can be added to bind to the negatively charged 
phosphates.  A salt concentration of one molar is generally sufficient for most microarray 
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experiments.45  Adjustment of the salt concentration can help to optimize hybridization, 
but such changes are usually small and insignificant.   
The concentrations of both the targets and the probes in a hybridization reaction 
are important to consider.  Hybridization reactions follow either pseudo-first order or 
second order reaction kinetics.29  When the target concentration is equal to or less than 
the probe concentration, second-order kinetics is achieved.29  Under these conditions, 
small differences in the concentration of either the target or probe can have a large impact 
on the reaction rate of hybridization.  When the concentration of the target is sufficiently 
higher than that of the cognate probe, pseudo-first order reaction kinetics is achieved and 
the target signal will be directly proportional to that of the target concentration.29  
Therefore, a 2-fold increase of target will produce a 2-fold increase in signal.  It can be 
difficult to build microarrays with precise concentrations of probe, as well as adding the 
exact amount of target to a hybridization reaction due to imprecise measurements and 
manufacturing techniques.  At least a 10-fold greater target concentration than probe is 
necessary to achieve such a reaction rate that variations due to imprecise microarray 
manufacturing methods can be minimized.29 
 A post-hybridization wash is necessary to remove unbound target strands from the 
array.  The wash consists of the array being soaked in two stringent salt solutions, the 
first more stringent than the second, with some type of agitation to help “clean” the array.  
Optimal stringency of the wash solutions is necessary to not only efficiently remove 
unbound target strands, but to also unbind random non-complimentary target/probe 
heteroduplexes.  Stringency is adjusted through salt concentrations and wash 
temperatures.  If the stringency of the wash conditions is too low, nonspecific binding 
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will increase creating false signals.  Relatively high-stringency conditions will give the 
best reproducibility.45 
Labeling Techniques 
 
 Attachment of a fluorescent molecule to a target sample, often termed “labeling,” 
requires the use of various techniques and materials.  Company provided protocols are 
followed when using commercial arrays, but with in-house arrays, a variety of options are 
available and the best choice to use tends to be determined by the type of experiments 
being performed.  Historically, all target samples were initially labeled in a direct 
manner, in which nucleotides attached to a fluorescent dye are incorporated into cDNA 
through reverse transcription.  The fluorescent dyes, like the commonly used Cy3 and 
Cy5 dyes, are attached to one of the four nucleotides, usually dTTPs or dCTPs, and 
become incorporated into the cDNA at the complimentary dATP (or dGTP) position of 
the mRNA strands.  However, there are some problems associated with direct labeling.  
First, the number of fluorescent molecules that are incorporated into a cDNA strand are 
directly proportional to the number of complimentary nucleotides in the mRNA strand.  
In the case of Cy3-conjugated dTTPs, the number of Cy3 molecules incorporated into a 
cDNA strand will vary based on the number of dATPs in the mRNA strand, and longer 
transcripts will invariably have a stronger signal potential than shorter transcripts.  
Second, the fluorescent molecules are bulky and tend to create interference during 
reverse transcription.58  The result is a variation in labeling efficiency among different 
transcripts.  Third, mostly in response to the second issue, direct-labeling protocols can 
call for up to 50-100µg of starting total RNA.  These large amounts of total RNA can be 
difficult to produce and are not typically ideal for most clinical applications.  One method 
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used to circumnavigate this problem has been to amplify RNA prior to labeling,53,54,62,74 
but the extent of accuracy and precision of that approach is still under question. 
Recently, other labeling techniques have become popular including an indirect 
method of labeling cDNA.  In this method, amino-modified (amino-allyl) nucleotides, 
instead of fluorescent-conjugated nucleotides, are incorporated into the cDNA through 
reverse transcription.  Once more, only one of the four nucleotides is modified. These 
amino-allyl nucleotides are considerably less bulky and thus are incorporated with greater 
efficiency.  The reactive fluorescent Cy3 and Cy5 dyes are then conjugated to the amino-
allyl nucleotides though a chemical coupling step.  Labeling efficiency is much higher in 
an indirect labeling approach; however, this does not resolve the issues of base 
composition or length of transcripts.  Direct labeling still offers one advantage over 
indirect labeling in that the direct approach is almost always less expensive than the 
indirect approach.   
 Genomic DNA (gDNA) can also be labeled with a fluorophore using direct or 
indirect techniques.  The fluorophores are incorporated through PCR instead of reverse 
transcription.  An alternative approach would be to add the fluorophore enzymatically at 
the end of a DNA strand using terminal transferase.  Terminal labeling is useful when 
labeling small strands of DNA where PCR would be difficult.  While this approach 
would attach only one fluorescent molecule to each strand, the problem of fluorescence 
intensity due to base composition and transcript length is eliminated.    
 Cy3 and Cy5 have been commonly used in microarray experiments as the 
fluorophores of choice, however, there are others on the market that claim a superior 
performance.  The Alexa Fluor family from Invitrogen (Carlsbad, California, USA) is 
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one example.  The claim is that the conjugates of Alexa 546 fluoresce are at least twice as 
bright as that of the Cy3 conjugates.63  Affymetrix uses a fluorophore from the 
streptavidin family, which has a very strong affinity for biotin.  Using an entirely 
different approach, Affymetrix protocols create cDNA from mRNA through reverse 
transcription, as is standard, but then continue to produce large amounts of cRNA 
through in vitro transcription.  During this amplification process, mRNA is amplified 
100-fold7 allowing for large amounts of cRNA to be hybridized to a GeneChip.  In 
addition to amplification, the transcription step also incorporates biotinylated nucleotides.  
The biotinylated cRNA is first hybridized to the arrays and then coupled with streptavidin 
phycoerythrin to provide the fluorescent signal.  To further increase the signal strength, 
biotinylated antibodies are attached to the streptavidin phycoerythrin and more 
streptavidin phycoerythrin is added to the mixture to bind to the biotin on the antibodies.   
 
Bacterial Pathogens 
 
Bovine diseases are usually identified through a combination of clinical 
observations made by veterinarians and ranchers and diagnostic tests performed in a 
laboratory.  A description of clinical signs and symptoms of the diseases studied in this 
project, the causative pathogens, and current techniques employed to detect them are 
provided in order to help convey the impact that the pathogens have on livestock and why 
further advancement in detection techniques for these pathogens is important.  Though 
the following are descriptions of individual pathogens and the related diseases, it is 
important to note that, in terms of respiratory diseases, it is common for multiple 
pathogens to be involved.   
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The following pathogens were selected for this project because they are common 
causes of infection afflicting livestock each year in the U.S.  These diseases are generally 
not found in U.S. livestock in epidemic form, but rather as common diseases encountered 
of importance to U.S. livestock.  U.S. ranchers regularly report individual or group cases, 
and local veterinarians, veterinary diagnostic laboratories and the ranchers themselves 
usually deal with these cases as they arise.  Often, the course of action is to isolate 
infected cattle to limit the spread of disease and treat animals accordingly.  
 
Pasteurella multocida 
 Pasteurella multocida subspecies multocida is the primary pathogen responsible 
for hemorrhagic septicemia in cattle, a disease that targets the respiratory system and 
causes excessive salivation and nasal discharge with swelling in the pharyngeal and 
ventral cervical regions.  Cattle with hemorrhagic septicemia usually die within 24 hours 
of the first recognizable signs due to respiratory distress.  Post-mortem observations 
include visible congestion of the mucous membranes, widely distributed lesions and 
hemorrhage and edema of the tissues of the head and neck.12 
 Laboratory diagnosis includes bacterial isolation from heparinized blood or select 
tissues, biochemical testing, special staining and observing colony characteristics.  
Moreover, there are immunological tests that include a rapid slide agglutination test for 
capsular typing, an indirect hemagglutination test for somatic typing, agar gel 
immunodiffusion tests, and counter immunoelectrophoresis that can identify the 
pathogenic P. multocida serotypes.1  PCR techniques have also been developed to detect 
P. multocida in tissue.14,49,56,70 
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Histophilus somni (Haemophilus somnus) 
 Historically thought of primarily as a nervous system pathogen that causes 
thromboembolic meningoencephalitis (TEME), Histophilus somni has the ability to 
attack numerous different cell types within a cow’s body.  Thus the disease is now 
referred to as the “Haemophilus somnus complex.”  The respiratory form of the disease 
causes severe pneumonia and death.  The reproductive and urinary tract form leads to 
long-term urinary tract infections and can cause abortions.  The septicemic form is 
manifested by many different clinical signs.  There are also miscellaneous forms of the 
disease that can infect such systems as the eyes and ears.  Ultimately, if left untreated, 
one form of the disease can lead to other forms of the disease.44   
Current techniques for diagnosis greatly rely on clinical signs and bacterial 
culture.  Ancillary serological tests are available including a microagglutination test, tube 
agglutination tests, a complement fixation test, an ELISA, and a technique that identifies 
a H. somni antigen by using monoclonal antibodies.44  A PCR test for the detection of H. 
somni in pure and mixed cultures has also been suggested, but is not cost-effective when 
compared to microbiological diagnostic techniques.3 
 
Mannheimia (Pasteurella) haemolytica 
 Mannheimia haemolytica, along with P. multocida, is one of the primary 
pathogens responsible for pneumonic pasteurellosis, commonly known as “shipping 
fever.”   M. haemolytica normally resides in the upper respiratory tract of a cow and tends 
to become pathogenic during suppression of the immune system, often a result of stress 
(e.g. during shipping) and concurrent viral infections.  The disease is typically observed 
in feeder calves and can range from acute to chronic conditions with morbidity levels 
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reaching 35% and mortality between 5-10%.  Diagnosis primarily relies on bacterial 
isolation in conjunction with clinical assessment2 and histopathologic examination.  A 
PCR test that isolates the lkt gene in M. haemolytica has also been demonstrated, but it 
lacks species specificity.26,30   
 
Arcanobacterium (Actinomyces) pyogenes 
Arcanobacterium pyogenes is an opportunistic pathogen responsible for a wide 
variety of diseases, from arthritis, to mastitis, to pneumonia.  Abscesses are often 
associated with A. pyogenes infections, and can target almost every organ and tissue in a 
cow.  Diagnosis is primarily confirmed by isolation of the bacterium from the infected 
tissue.17   
 
Escherichia coli 
Escherichia coli is the most predominant species of normal flora within the 
bovine intestine.  Most strains are non-pathogenic, however, pathogenic strains cause 
severe disease in young animals.  Young calves (1-10 weeks) are the most susceptible to 
pathogenic E. coli infections, which commonly include enteritis (white scours, enteric 
colibacillosis) and septicemia (colisepticaemia).  Enteric colibacillosis is primarily caused 
by Enterotoxigenic E. coli (ETEC) infections.  Calves are also subject to 
Enterohaemorrhagic E. coli (EHEC) infections, which include the highly pathogenic E. 
coli O157:H7 strain, and Enteropathogenic E. coli (EPEC) infections. 
Historically, diagnosis of E. coli infections required positive culture of the 
pathogenic species in conjunction with gross clinical evidence such as systemic lesions.  
While culture is still useful in identifying E. coli strains, current techniques like PCR are 
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widely used for diagnostic detection of pathogenic species61 using virulence gene 
identification.  
 
Salmonella typhimurium and Salmonella dublin 
 Bovine salmonellosis is caused by a number of different serovors of Salmonella 
species.  However, the most incriminating Salmonella by far found in cases of bovine 
salmonellosis are typhimurium and dublin.  Salmonellosis usually manifests as septicemia 
or acute or chronic enterocolitis.  Salmonellosis is highly contagious as the Salmonella 
species are resilient in the environment.  The enteric syndrome of salmonellosis is more 
common in cattle overall, and the septicemic syndrome is more common in calves.  S. 
dublin is observed more often in the septicemic syndrome of the illness.  Septicemic 
salmonellosis has a much higher death rate than the enteric syndrome, however, enteric 
salmonsellosis still has a fatality rate of about 50% or greater.   
Diagnosis is based on a combination of antemortem and postmortem diagnostics 
including culture of the organism.  Salmonella sp. can be isolated from tissue or fecal 
material and from blood in septicemic cases.  Serological tests (ELISA, serum 
agglutination, complement fixation) are also available for antemortem Salmonella sp. 
detection, as well as antibody detection in septicemic animals.71 
 
Objectives of This Report 
 
The objective of this project was to correctly identify the above bovine pathogens 
individually from tissue spiked with a mixture of bacteria using microarray technology.   
Therefore, two arrays were designed using completely different approaches.  A sub-
objective to this project was to successfully design the arrays for detection of pathogenic 
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DNA without a need for PCR amplification.  Our first arrays were homemade and 
designed in-house using equipment and materials that were available in the Center for 
Integrated BioSystems (CIB) at USU.  These arrays had probes that targeted the 16S 
ribosomal RNA (rRNA) gene for each pathogen.  Commercial GeneChips from 
Affymetrix were utilized for our second array design.  Numerous genes, including the 
16S rRNA gene, were represented on these arrays for each pathogen.  While the genes 
represented on this array were selected in-house, Affymetrix designed the probes and 
built the actual arrays.  This report covers the research performed using both array 
platforms. 
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CHAPTER II  
IN-HOUSE ARRAYS 
 
Introduction 
 
Our aim was to design and build an in-house microarray for the detection of 
common bovine pathogens in a cost-effective manner using equipment and materials that 
were available at the CIB.  In a study that compared a number of different slide types, the 
nylon-mounted membrane slides seemed to provide the lowest detection limit capabilities 
while providing the highest signal-to-noise ratios.28  An additional advantage of nylon-
mounted slides is they are generally less expensive among different slide types and are 
adaptable to multiple protocols that use common reagents found in most laboratories.   
The array was designed to detect Pasteurella multocida, Manheimia haemolytica, 
Histophilus somni, and Arcanobacterium pyogenes, common pulmonary pathogens that 
afflict U.S. livestock, using their 16S ribosomal RNA genes for differentiation.  These 
pathogens were individually hybridized to the designed array to determine if the array 
would be sufficient for further testing with bovine tissue.   
 
Materials and Methods 
 
Designing Probes 
 The 16S ribosomal RNA gene was used to distinguish between different 
pathogens.  16S sequence for each pathogen was obtained from GenBank.  Numerous 
16S gene sequences were obtained for the same pathogen representing different strains 
available from GenBank (Table 1).  Sequences were aligned using Invitrogen’s Vector 
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NTI software.  For each pathogen, six regions of the 16S gene were manually selected for 
use in the design of target probes.  The regions selected were homologous with other 16S 
sequences of the same pathogen species, but unique from the 16S sequences of the other 
pathogens.  For each region, both the sense and anti-sense sequences were used to design 
complimentary probes (designated A and B).  This allowed for a total of twelve different 
sequences to be used for probe design for each pathogen (Table 2).  Sequences were 20-
22 bases in length with a calculated melting temperature of 55°C± 1°C according to 
Vector NTI calculations.  Integrated DNA Technology (IDT, Coralville, IA) synthesized 
the sequences for the probes.  Mismatched probes were also designed for each probe 
sequence to help differentiate positive signal from background noise by changing two 
nucleotides with their compliment.  The positions of these changes were manually 
selected, based on maintaining a melting temperature of ±+- 1 °C difference from that of 
the perfect matched sequence.  Mismatched probes are designated with a “MM” in table 
2. 
 
Table 1.  List of GenBank Sequences Aligned to Select Probes for In-house Arrays 
 
 
 
 
 
 
 
 
A. pyogenes ACYRR16S X79225
H. somni AF031936 AF549392 AF549396 AF549400
AF549387 AF549393 AF549397 AF549401
AF549388 AF549394 AF549398 AF549403
AF549391 AF549395 AF549399 AF549404
M75046
M. haemolytica M75080 PHU57066 PHU57069 PHU57071
M75063 PHU57068 PHU57070 PHU57072
P. multocida AY078996 AY299306 AY299316 DQ286927
AY078997 AY299307 AY299317 DQ286928
AY078998 AY299308 AY299318 DQ286929
AY078999 AY299309 AY299319 DQ288145
AY079000 AY299311 AY324032 DQ288146
AY299304 AY299313 AY683485 M35018
AY299305 AY299315 AY999017
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Table 2. Position and Sequence of In-house Array Probes 
Well  
Position 
Probe Name Sequence 
A01 M. haemolytica 16S 1A TGGAGGGGGATAACTACTGG 
A02 M. haemolytica 16S 1A MM TCGAGGGGGATAACTACTCG 
A03 M. haemolytica 16S 1B CCAGTAGTTATCCCCCTCCA 
A04 M. haemolytica 16S 1B MM CGAGTAGTTATCCCCCTCGA 
A05 M. haemolytica 16S 2A TTGGTGAGGTAAAGGCTCAC 
A06 M. haemolytica 16S 2A MM TTGGTCACGTAAAGGCTCAC 
A07 M. haemolytica 16S 2B GTGAGCCTTTACCTCACCAA 
A08 M. haemolytica 16S 2B MM GTGACCCTTTACGTCACCAA 
A09 M. haemolytica 16S 3A CAGTCGATTGACGTTAATCACA 
A10 M. haemolytica 16S 3A MM CAGTCGATTGACGTTAATGAGA 
A11 M. haemolytica 16S 3B  TGTGATTAACGTCAATCGACTG 
A12 M. haemolytica 16S 3B MM TGTCATTAAGGTCAATCGACTG 
B01 M. haemolytica 16S 4A GCCATAAGATGAGCCCAAGT 
B02 M. haemolytica 16S 4A MM GCCATAAGATCAGCCCAACT 
B03 M. haemolytica 16S 4B ACTTGGGCTCATCTTATGGC 
B04 M. haemolytica 16S 4B MM ACTTCGGCTCATCTTATGCC 
B05 M. haemolytica 16S 5A AAAGGGTGGGACTTTCGG 
B06 M. haemolytica 16S 5A MM AAAGGGTGGGAGTTTCCG 
B07 M. haemolytica 16S 5B CCGAAAGTCCCACCCTTT 
B08 M. haemolytica 16S 5B MM CCCAAAGTCCCAGCCTTT 
B09 M. haemolytica 16S 6A AGCTGTAAGGTGGAGCGAAT 
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B10 M. haemolytica 16S 6A MM AGCTGTAAGCTGGACCGAAT 
B11 M. haemolytica 16S 6B ATTCGCTCCACCTTACAGCT 
B12 M. haemolytica 16S 6B MM ATTCGCTCCAGCTTACACCT 
C01 H. somni 16S 1A GTGATGAGGAAGGCGATTAGT 
C02 H. somni 16S 1A MM GTCATCAGGAAGGCGATTAGT 
C03 H. somni 16S 1B ACTAATCGCCTTCCTCATCAC 
C04 H. somni 16S 1B MM ACTAATCGCCTTCCTGATGAC 
C05 H. somni 16S 2A AGCATGTTAGGGTGGGAACT 
C06 H. somni 16S 2A MM AGCATCTTACGGTGGGAACT 
C07 H. somni 16S 2B AGTTCCCACCCTAACATGCT 
C08 H. somni 16S 2B MM AGTTCCCACCGTAAGATGCT 
C09 H. somni 16S 3A CACGCAGGTGGTGACTTAAG 
C10 H. somni 16S 3A MM CAGGCAGCTGGTGACTTAAG 
C11 H. somni 16S 3B CTTAAGTCACCACCTGCGTG 
C12 H. somni 16S 3B MM CTTAAGTCACCAGCTGCCTG 
D01 H. somni 16S 4A CAGCATTTCAGACTGGGTGA 
D02 H. somni 16S 4A MM CACCATTTCAGAGTGGGTGA 
D03 H. somni 16S 4B TCACCCAGTCTGAAATGCTG 
D04 H. somni 16S 4B MM TCACCCACTCTGAAATGGTG 
D05 H. somni 16S 5A AGATACTGACGCTCGAGTGC 
D06 H. somni 16S 5A MM AGATACTCACGCTGGAGTGC 
D07 H. somni 16S 5B GCACTCGAGCGTCAGTATCT 
D08 H. somni 16S 5B MM GCACTCCAGCGTGAGTATCT 
D09 H. somni 16S 6A CAGAGATGGTGGTGTGCCTA 
D10 H. somni 16S 6A MM CACAGATGGTGGTCTGGCTA 
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D11 H. somni 16S 6B TAGGCACACCACCATCTCTG 
D12 H. somni 16S 6B MM TAGCCACACCACCATCTGTG 
E01 A. pyogenes 16S 1A CCTTGTCTTTGGGATAAGCC 
E02 A. pyogenes 16S 1A MM CCTTCTCTTTCGGATAAGCC 
E03 A. pyogenes 16S 1B GGCTTATCCCAAAGACAAGG 
E04 A. pyogenes 16S 1B MM GGGTTATCCCAAACACAAGG 
E05 A. pyogenes 16S 2A GAGTGTGGTAGGGGTAATTGG 
E06 A. pyogenes 16S 2A MM GAGTCTGGTAGCGGTAATTGG 
E07 A. pyogenes 16S 2B CCAATTACCCCTACCACACTC 
E08 A. pyogenes 16S 2B MM CCAATTAGCCCTACGACACTC 
E09 A. pyogenes 16S 3A GGTTACTGGGCCATTACTGAC 
E10 A. pyogenes 16S 3A MM GGTTAGTGGCCCATTACTGAC 
E11 A. pyogenes 16S 3B GTCAGTAATGGCCCAGTAACC 
E12 A. pyogenes 16S 3B MM GTCAGTAATGGCCGACTAACC 
F01 A. pyogenes 16S 4A GGCTTGACATACACTGCGAT 
F02 A. pyogenes 16S 4A MM GGCTTCACATACACTGCCAT 
F03 A. pyogenes 16S 4B ATCGCAGTGTATGTCAAGCC 
F04 A. pyogenes 16S 4B MM ATCGCACTGTATGTGAAGCC 
F05 A. pyogenes 16S 5A GTGGTGTACAGGTGGTGCAT 
F06 A. pyogenes 16S 5A MM GTGGTGTACAGCTGCTGCAT 
F07 A. pyogenes 16S 5B ATGCACCACCTGTACACCAC 
F08 A. pyogenes 16S 5B MM ATGCACCACGTGTAGACCAC 
F09 A. pyogenes 16S 6A GCCTGTGAGGGTGAGCTAAT 
F10 A. pyogenes 16S 6A MM GCCTGTGAGGCTGAGGTAAT 
F11 A. pyogenes 16S 6B ATTAGCTCACCCTCACAGGC 
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F12 A. pyogenes 16S 6B MM ATTAGCTCACCCTGAGAGGC 
G01 P. multocida 16S 1A TAACTGTGGGAAACTGCAGC 
G02 P. multocida 16S 1A MM TAACTGTGGCAAACTGGAGC 
G03 P. multocida 16S 1B GCTGCAGTTTCCCACAGTTA 
G04 P. multocida 16S 1B MM GCTGCACTTTCCCACACTTA 
G05 P. multocida 16S 2A CGGTAATGAGGAAGGGATGT 
G06 P. multocida 16S 2A MM CGGTTATCAGGAAGGGATGT 
G07 P. multocida 16S 2B ACATCCCTTCCTCATTACCG 
G08 P. multocida 16S 2B MM ACATCCCTTCCTGATAACCG 
G09 P. multocida 16S 3A ATTTGGGGATTGGGCTATAT 
G10 P. multocida 16S 3A MM ATTTGGGCATTGGCCTATAT 
G11 P. multocida 16S 3B ATATAGCCCAATCCCCAAAT 
G12 P. multocida 16S 3B MM ATATAGCCCAATGGCCAAAT 
H01 P. multocida 16S 4A GACTGCCAGTGACAAACTGG 
H02 P. multocida 16S 4A MM GACTGCCAGTGAGAAAGTGG 
H03 P. multocida 16S 4B CCAGTTTGTCACTGGCAGTC 
H04 P. multocida 16S 4B MM CCAGTTTGTGACTGGGAGTC 
H05 P. multocida 16S 5A CTCAGAGATGAGCTTGTGCC 
H06 P. multocida 16S 5A MM CTCAGAGATCACCTTGTGCC 
H07 P. multocida 16S 5B GGCACAAGCTCATCTCTGAG 
H08 P. multocida 16S 5B MM GGCAGAAGCTCATGTCTGAG 
H09 P. multocida 16S 6A ATACAGAGGGCAGCGAGAGT 
H10 P. multocida 16S 6A MM ATACAGAGGCCACCGAGAGT 
H11 P. multocida 16S 6B ACTCTCGCTGCCCTCTGTAT 
H12 P. multocida 16S 6B MM ACTGTCGGTGCCCTCTGTAT 
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Tailing Probes 
 A polyinosine tail was added to each oligonucleotide probe using terminal 
transferase.78  12nmols of each probe was synthesized by IDT in a deep-well 96-well 
plate.  Probes were diluted with TE buffer (pH 7.0) to a 10µM concentration.  The probes 
were then tailed with dITPs in a 20µl reaction that contained 10µl of 10µM probe 
oligonucleotides (IDT), 4µl 25mM CoCl (New England Biolabs, Ipswich, MA), 1µl 
20U/µl TdT (New England Biolabs), 4µl 5X TdT buffer (New England Biolabs), and 1µl 
10µM dITP (Roche Applied Science, Foster City, CA).  The reaction was incubated at 
37°C for 2 hours and then allowed to freeze at -20°C overnight.  After freezing, the 
reaction was thawed in a biological safety cabinet and allowed to completely evaporate 
for 24 hours.  After evaporation was complete, the oligonucleotide probes were 
reconstituted in a 1X TE buffer (pH 7.0) with 5% glycerol solution.  This TE 
buffer/glycerol solution helped to prevent evaporation of the probe solution during 
spotting of the microarrays.  
 
Spotting Microarrays 
Vivid microarray slides (Pall, East Hills, NY) were used as the platform for our 
experiments.  The Vivid arrays have a thin uniform nylon membrane that covers the glass 
slide, which is reported to improve the target/probe binding and reduces background over 
traditional glass slides.28  The Vivid slides were spotted with a QArraymini spotter 
(Genetix, Queensway, UK) following the manufacturer’s protocol using solid pins and 
were spotted at 10°C at 50% humidity.   
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Culturing Pathogens 
 Pure cultures of the pathogens were obtained from the American Type Culture 
Collection (ATCC, Manassas, VA).  A list of ATCC numbers is found in Table 3.  
Bacteria were streaked onto blood agar plates and were incubated under aerobic 
conditions at 37°C for 24-48 hours depending on the growth rate of each bacterial 
species.  Individual colony forming units (CFU) were selected for DNA extraction as 
needed.  The only exception was that A. pyogenes was incubated under anaerobic 
conditions.  All of the pathogens were isolated in pure culture the Utah Veterinary 
Diagnostics Laboratories (UVDL), Logan, UT.  PCR was used to confirm bacterial 
identity after DNA was extracted. 
 
 Table 3. ATCC Numbers of Pathogens for In-house Arrays 
 
 
 
 
 
 
 
 
Extracting DNA 
 DNA was extracted from bacterial CFU’s by lysing the cells with CTAB and 
purifying the DNA using a phenol/chloroform separation.5  DNA concentration and 
purity ratios were measured using a ND-1000 spectrophotometer (Nanodrop, 
Wilmington, DE). 
Pathogen ATCC # 
P. multocida 12945 
M. haemolytica 55518 
H. somni 700025 
A. pyogenes 49698 
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PCR 
 PCR was used to confirm the identity of each isolate by amplifying the 16S 
ribosomal genes using primers listed on Table 4.  Also, as will be discussed later, it was 
necessary to amplify the 16S ribosomal gene in each group or sample through PCR prior 
to adding a fluorescent label.  The initial objective was to achieve sufficient labeling 
without prior amplification, but was unsuccessful.  The PCR protocol was as follows: 
200-300ng of gDNA was added to a 50µl reaction containing 1µl Advantage 2 
polymerase (Clontech, Mountain View, CA), 1µl dNTPs (10µM) (New England Biolabs), 
1µl 10µM forward and reverse primers (IDT) each, and 5µl 10X buffer (Clontech).  
Reactions were initially denatured (95°C-1 min), followed by 30 amplification cycles 
(95°C-30s, 57°C-30s, 68°C-3min), and completed with a final extension step (68°C-
3min).  PCR products were run on a 1% TAE gel stained with 0.5X SYBR Safe 
(Invitrogen) to confirm successful amplification. 
 
Table 4.  Primer Sequences Used to Amplify the 16S Gene of Bovine Pathogens  
 
 
 
 
 
 
 
 
 
Pathogen Primers 
P. multocida F-5’-AACACATGCAAGTCGAACGG 
R-5’-TGACGGGCGGTGTGTACAA 
M. haemolytica F-5’-TCAGATTGAACGCTGGCGGC 
R-5’-CACACCCCAGTCATGAATCATACCG 
H. somni F-5’-GAGTGGCGGACGGGTGAGTAAA 
R-5’-ACTTCTGGTACAACCCACTCCCATG 
A. pyogenes F-5’-GCGTGCTTAACACATGCAAGTCG 
R-5’-TCACCGCAGCGTTGCTGATC 
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Labeling DNA 
 16S ribosomal amplicons (2 µg) were labeled with Alexa Fluor 546, because of its 
superior fluorescence compared to Cy3,63 using Invitrogen’s BioPrime Plus Array CGH 
Indirect Genomic Labeling System. The protocol was followed according to 
manufactures’ instructions except the optional DNA digestion step prior to labeling was 
skipped and was regarded as unnecessary for this study. 
 
Hybridization, Washing, Scanning 
 Vivid slides were soaked in a preheated pre-hybridization buffer (100mM NaPO4, 
20% SDS, 0.1g Casein) for 30 minutes at 45°C, after which excess buffer was allowed to 
run off.  A total of 1µg of labeled target was added to a hybridization buffer (100mM 
NaPO4, 20% SDS, 0.1g Casein) for a total volume of 100µl.  Hybridization cocktail was 
heated to 95°C for 5 minutes to denature the DNA.  The entire hybridization cocktail, 
100µl, was pipetted onto the array, after which a cover slip was laid.  Arrays were 
incubated in a Boekel Scientific Hybridization Oven (model # 241000) at 45°C for 2 
hours.  Filter paper soaked with pre-hybridization buffer was laid in the oven to retain 
humidity within the chamber.  Arrays were washed in a preheated “Wash A” solution 
(2X SSC, 0.5% SDS) at a range of temperatures (40°C-55°C) for 30 minutes with 
agitation.  During this step, cover slips were removed if they did not already slide off by 
themselves as a result of shaking.  Arrays were then transferred to a preheated “Wash B” 
solution (0.5X SSC, 0.5% SDS) and washed at a range of temperatures (40°C-55°C) for 
30 minutes with agitation.  Arrays were finally transferred to a rinse solution (0.5X SSC) 
at room temperature for about 10 seconds with agitation.  The slides were dried by 
spinning them in 50mL conical tubes in a centrifuge at 3000 rpm for 5 minutes.  Arrays 
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were immediately scanned with an Axon Genepix 4200A scanner (Molecular Devices 
Sunnyvale, CA) with a PMT setting of 400.   
 
Data Analysis 
Scanned images of arrays were analyzed with GenePix Pro, v5.1 (Molecular 
Devices).  For each hybridization spot, a foreground and background signal was 
calculated.  The foreground signal was then divided by the background signal to get a 
signal ratio.  A signal ratio of 2 or higher was considered a positive signal.   
 
Results 
 
Layout of In-house Array 
The organisms, P. multocida, H. somni, A. pyogenes, and M. haemolytica, are 
represented on the in-house array.  Each array consisted of 10 repeated regions as shown 
in figure 1.  Each region was divided into four quadrants.  The two left quadrants were 
blanks that acted as negative controls for hybridization.  The top right quadrant contained 
all PM probes for all pathogens, while the bottom right quadrant contained the 
corresponding MM probes.  Probes representing the 16S ribosomal gene for P. multocida 
were located within the 1st and 2nd columns as shown in the red box of figure 1.  Probes 
for A. pyogenes are found in the 3rd and 4th columns as shown in the yellow box, H. somni 
in the 5th and 6th columns as shown in the blue box, and M. haemolytica in the 7th and 8th 
columns as shown in the white box.  The position of a MM probe matches that of its 
corresponding PM probe. 
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Figure 1. Layout of the in-house array 
 
 
 
 
 
 
 
 
 
 
Figure 1. Layout of the in-house array.  Each pathogen is represented by 12 PM probes 
and 12 MM probes.  Each block of probes is repeated on the array 10 times.                  
(A) P. multocida (B) A. pyogenes (C) H. somni (D) M. haemolytica 
 
 
Hybridizing Genomic DNA 
 The initial aim of this study was to detect proper signals with hybridized gDNA 
without amplification.  This possibility was tested by hybridizing whole gDNA, sheared 
DNA by use of a sonicator, and enzymatically digested DNA using restriction enzyme 
RSA.  However, this procedure was not able to produce any signal patterns (figure 2), nor 
were any significant changes seen with the signal as hybridization and wash conditions 
were changed.  Ultimately, gDNA signals were so weak that the strongest signals seen in 
the images in figure 2 corresponded to the greatest indent on the nylon membrane 
inadvertently created from spotting the arrays.  Due to these findings, it became 
  A     B     C     D 
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necessary to amplify the 16S gene for each pathogen through PCR in order to enhance 
signal patterns.  
 
 
 
 
 
 
 
 
Figure 2. Three arrays hybridized with unamplified P. multocida gDNA.  
(a) Whole gDNA (b) sheared DNA (c) restriction enzyme-digested DNA.   
No signal pattern was detected. 
 
Optimizing Washing Conditions 
 P. multocida amplified gDNA was hybridized to a series of arrays, all at 45°C.  
Wash temperatures were varied from 40°C to 55°C to find an optimal wash temperature.  
From a series of experiments, the best hybridizations occurred in wash conditions at 50°C 
where the positive signals were consistently easier to distinguish from the background.  
As wash temperatures decreased to 45°C and less, an increase in signal was seen for both 
PM and MM probes indicating the possibility of non-specific binding. At wash 
temperatures higher then 50°C, most of the probes produced lower signals at or near 
background levels.  Based on these observations and information by Loy et al., 50°C was 
chosen as optional wash temperature.51-52   
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Hybridization Patterns 
 Numerous P. multocida arrays were initially run to optimize conditions until a 
strong hybridization pattern for P. multocida became apparent (figure 3).  With the 
exception of probes designated P. multocida 16-3 A&B , all P. multocida probes showed 
the highest signals, though the analyzed signal values never reached a level of 2, which 
was the designated positive signal threshold.  However, despite this limitation, the green 
hybridization pattern for P. multocida, within the first two columns in the PM quadrant, 
was easily distinguishable from background noise.  
As amplified DNA from the other pathogens was introduced to the array, each 
produced a hybridization pattern of green spots within the columns of the PM quadrant 
corresponding to the correct pathogen.  In the arrays hybridized with A. pyogenes DNA, 
seven of the twelve probes showed strong signals, most with a value of 2 or greater 
(figure 4).  However, three MM probes consistently produced high signals, while one of 
the counterpart PM probes did not show any signal.  Amplified H. somni DNA 
hybridized well to its probes as all of the PM probes showed strong signals, though four 
were significantly less than the other eight (figure 5).  Arrays hybridized with amplified 
M. haemolytica DNA seemed to be the least successful (figure 6).  Only four probes, 
designated M. haemolytica 16-1 A&B and 16-4 A&B, had signal values higher than 2, 
which were followed distantly by 16-3 A&B.     
 Though some random signaling not associated with the target DNA in each of the 
arrays was observed, indicating a need for additional optimization, we were mostly 
concerned with probes M. haemolytica 16-1 A & 16-4 A, which produced strong signals 
in all arrays. 
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Figure 3. P. multocida hybridization pattern and signal intensities 
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Figure 4. A. pygenes hybridization pattern and signal intensities 
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Figure 5. H. somni hybridization pattern and signal intensities 
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Figure 6. M. haemolytica hybridization pattern and signal intensities.
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Discussion 
 
Our primary aim in this study was to design a microarray that could correctly 
detect specific bovine pathogens within infected cattle tissue.  Our secondary objective 
was to design a platform that would be relatively inexpensive compared to current 
standard microarray costs.  The overall aim was to provide an approach that could 
potentially challenge current veterinary diagnostic techniques in terms of accuracy, ease, 
safety, and cost-effectiveness.   
 
The Good 
After much trial and error in finding optimal assay conditions, we successfully 
hybridized gDNA from the four pulmonary pathogens, P. multocida, M. haemolytica, H. 
somni, and A. pyogenes, to the “in-house” microarray and produce distinct signal patterns 
for each pathogen.  The probes for each pathogen were arranged such that it was possible 
to identify the pathogen hybridized from the signal pattern alone without the need of 
additional software analysis.   
Not all of the probes designed for specific pathogens demonstrated successful 
hybridization with the target DNA.  Since this was the first trial phase, and thus only the 
first round of elimination, we were not surprised that there were some probes that refused 
to hybridize.  Overall, hybridization patterns repeated in each of the ten regions and were 
also consistent among repeated arrays.  With the current data being consistent, we feel it 
would be safe to remove the unsuccessful probes from future arrays and use only the 
successful probes for diagnostics.   
  
38 
There were a total of twelve probes for each pathogen that targeted the 16S 
ribosomal gene.  Probes for P. multocida had the highest success rate with 10 out of 12 
showing successful hybridization.  Both probe sets for H. somni and A. pyogenes had an 
average success rate of 58% (7/12 probes showed successful hybridization), which is 
sufficient for positive identification.  Probes for M. haemolytica had the lowest success 
rate with only 4 out of 12 probes showing successful hybridization.  However, two of the 
probes that target M. haemolytica also showed varied levels of signal when hybridized 
with the other pathogens, making them less useful for diagnosing mixed infections.  The 
corresponding MM probes also produced a signal that was equal to or less than the PM 
probes, and even on the M. haemolytica array, some MM signal was evident for these two 
probes.  This casts doubt as to whether these M. haemolytica signals were true signals.  
We feel that they were false positives created from some unknown hybridization issue, 
probably a technical issue, since the signals were evident to some degree in all of the 
hybridized arrays.  
 
The Bad 
We were able to produce distinct, visible signal patterns that confidently 
represented each pathogen, except M. haemolytica.  However, there are still additional 
challenges that will be faced in any future versions of these in-house arrays.  First, though 
the probes showed fairly good consistency in terms of whether the probe was successful 
or not at producing a signal, there was some signal variation that seemed to be dependant 
on the probe’s physical location on the array.  The strength of the signal overall tended to 
be stronger on one side of the array than the other.  As you view the arrays presented in 
this report, from top to bottom, the strength of the signal was typically stronger on the 
  
39 
bottom of the array.  We feel this represents a mechanical error with the scanner since 
this pattern was consistent with each array regardless of which way the array was inserted 
into the scanner.  This could certainly be corrected in the future, but no doubt allowed a 
bias to enter in the calculations made for the signal strength of each probe during this 
series of experiments. 
Second, these arrays were prone to random spots, smears, and scars that produced 
extra noise as can be seen on the pictures of each array.  These extra blemishes affected 
the signal of any probes that shared the same physical location with the blemishes on an 
array.  These blemishes were the result of the arrays being exposed to a “dirty” 
environment during processing.  The issue could be corrected by improving the 
processing protocols and working environment.  Taking steps to “clean” the procedure 
and working environment should lessen the formation of these blemishes. 
All of the previously mentioned obstacles could be resolved with improved 
versions of the array through selecting the appropriate probes, optimizing hybridization 
conditions, including the working environment, and tuning the necessary equipment.  The 
third major issue, however, presented a problem that was not expected.  One of our initial 
aims was to produce positive signal patterns by hybridizing whole gDNA without the 
need for extra sample preparation (other than labeling).  In our initial attempts, we were 
unable to achieve that objective with these arrays.  In order to produce the desired 
signals, it was necessary to first amplify the 16S gene sequence through PCR using 
species-specific primers.  In our opinion, this was an unacceptable step in preparing 
target DNA.  Using this procedure, one could simply identify the bacterial species 
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through the PCR amplification step, and further analysis by hybridization of the 
amplified sequence to a microarray was only redundant. 
 
Conclusion 
 
 
We designed, built, and processed our arrays in-house, and were encouraged by 
being able to produce distinct signal patterns for each of the hybridized pathogens.  We 
came across a number of obstacles, both technical and mechanical, but felt that with time 
most could be resolved.  Our most concerning obstacle was that a positive signal was 
only possible by first PCR amplifying the 16S gene sequence.  Due to this unforeseen 
issue, more efficient array options were explored.  
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CHAPTER III  
AFFYMETRIX ARRAYS 
 
Introduction 
 
For detection of specific bovine pathogens common in the US we designed a 
custom Affymetrix GeneChip, STYLMONOa520430F.  We were interested in detecting 
pathogens that target various organs; P. multocida, M. haemolytica, H. somni, and A. 
pyogenes from the lung and nasal cavities, and S. typhimurium, S. dublin, and E. coli 
from the liver, lung, kidney, and spleen.  These pathogens were hybridized to the 
GeneChip both individually and spiked into bovine tissue prior to extraction and 
hybridization. 
The STYLMONOa520430F GeneChip was primarily designed for S. 
typhimurium strain LT2 and L. monocytogenes strain EGDe, and their entire genomes are 
represented on the array, including a series of intergenic regions.75  Of these two 
pathogens, only S. typhimurium was of interest in this study.  L. monocytogenes genes 
were only used to help calculate background signal.  For the remaining pathogens, only a 
select set of genes were represented due to limited space available on the array.  
 
Material and Methods 
 
 
Array Design 
In total 4639 genes were selected for probe design: 56 genes for P. multocida, 3 
genes for M. haemolytica¸ 2 genes for H. somni¸ 2 genes for A. pyogenes, 4518 genes for 
S. typhimurium, 8 genes for S. dublin, and 50 genes for E. coli (Appendix A).  The 
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strategy for probe design depended greatly on whether the specific bacterial genome was 
sequenced.  Ultimately, probes were designed to be specific to the target bacterium 
without significant cross-hybridization.  The sequenced genomes of P. multocida Pm70 
and E. coli 0157:H7 were run through ERGO (a web-based genome-comparison analysis 
program) to identify a list of possible genes from which to design probes for the array.  
With that program, the list of potential candidate genes useful for the array was reduced 
from thousands to only hundreds for each bacterium.   
Select candidate gene sequences were analyzed using BLAST from the National 
Center for Biotechnology Information (NCBI) to search for genes that were the most 
unique to the target bacterium.  Using an E score of 1e-5 as the cutoff for significance, 
genes were selected for probe design if they produced a significant hit (<1e-5) with only 
that of its target bacterium.  If there was a significant match to another organism other 
than the target bacterium, the sequence was removed from consideration.  According to 
Affymetrix standard procedure, probes were to be designed only from within the first 600 
bases of a selected gene, so any homologous sequences beyond 600 bases, regardless of 
the E score, were ignored.  There were a few cases in which genes were selected for 
probe design even though the gene sequence had a significant hit (<1e-5) with another 
organism besides that of the target bacterium.  In these cases, the genes were admitted 
only because there was a need for more probes and these other non-target organisms were 
not closely related to the target bacterium nor were they related to human, bovine, or 
other farm species, and were thus less of a concern for potential contamination.   
For M. haemolytica, A. pyogenes, S. dublin, and H. somni, whose genomes are not 
yet sequenced, we selected genes based on a review of the literature: lktA26,30 and lpsA 
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for M. haemolytica,37 plo for A. pyogenes,42 rpoB for H. somni.57  The H. somni  genome 
has been sequenced (as of Dec 2006), but was not published at the time the array was 
designed.  There are only seven sequences available in genbank for S. dublin of which the 
functions are unknown.  However, since the sequences were specific to S. dublin, all 
seven genes were included.  In addition to the gene search and literature review, the 16S 
and 23S gene sequences were also included for each pathogen. 
The S. typimurium LT2 genome was used to design the probes for S. 
typhimurium.75  The probe sets designed for S. typhimurium differ from the probe sets of 
the other pathogens of interest in that the entire genome is represented instead of a select 
number of genes. 
 Standard Affymetrix protocols for designing GeneChips include the design and 
synthesis of MM probes for every probe set.  Affymetrix utilizes MM probes to increase 
sensitivity in expression arrays by removing background signal caused by higher levels of 
non-specific binding as a result of using short oligonucleotide probes.  However, since 
the STYLMONOa520430F GeneChip was used as a diagnostics array in this study, it 
was opted to exclude the MM probes in order to preferably allow more room for PM 
probes.  Thus this GeneChip contained only PM probes. 
 
Culturing Pathogens 
 Pure cultures of each bacterium were obtained from either the ATCC or from 
environmental strains that were isolated from tissues of cattle at the UVDL.  A list of the 
sources is found on Table 5.  Unless otherwise stated elsewhere in this report, ATCC 
strains were hybridized individually to test for cross hybridization, and the field isolates 
were spiked into tissue homogenates before DNA extraction and hybridization to confirm 
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that specific detection was possible while mixed with Bovine DNA.  With the exception 
of A. pyogenes, the pathogens were streaked onto blood agar plates and were incubated 
under aerobic conditions at 37°C for 24-48 hours depending on the growth rate of the 
bacterium.  A. pyogenes was incubated under anaerobic conditions.  Individual CFUs 
were selected for DNA extraction as needed.  
 
Table 5. List of ATCC Numbers of Pathogens for Affymetrix Arrays 
Pathogen ATCC # or Field Isolate Source 
P. multocida 12945 ATCC 
55518 ATCC 
M. haemolytica 
Field Isolate UVDL 
700025 ATCC 
H. somni 
Field Isolate UVDL 
49698 ATCC 
A. pyogenes 
Field Isolate UVDL 
35987 ATCC 
S. typhimurium 
Field Isolate UVDL 
Field Isolate 1 UVDL 
S. dublin 
Field Isolate 2 UVDL 
35150 
Strain O157:H7 
ATCC 
Field Isolate 1 UVDL 
Field Isolate 2 (078:H11) UVDL 
E. coli 
Field Isolate 3  
(Non-pathogenic) 
UVDL 
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DNA Extraction 
 DNA was extracted from each pathogen by lysing the cells with CTAB and 
purifying the DNA using a phenol/chloroform separation.5  DNA was also extracted from 
bovine lung, kidney, liver, and spleen using QIAGEN’s DNeasy Protocol for Animal 
Tissues.   
DNA was also extracted using the QIAGEN’s DNeasy Protocol for Animal 
Tissue from bovine tissue homogenates that were spiked with bacterial cocktails to 
simulate multi-pathogen infections.  Ten to 100 CFUs of each bacterium were added to 
25 mg of each bovine tissue (10 mg of spleen) before extraction of DNA.  
 
PCR 
 PCR was used to confirm that specific bacterial DNA was present in the spiked 
tissue samples.  200 ng of DNA from the spiked tissue samples was then used as starting 
material.  The 16S gene of each bacterium was targeted with specific primers (Table 6).  
The GoTaq Green Master Mix protocol (Promega; P/N M7122) was followed using 25ul 
reactions that were initially denatured (95°C-2 min), followed by 30 amplification cycles 
(95°C-30s, 63°C-30s, 72°C-2min), and completed with a final extension step (72°C-
5min).  PCR products were run on a 1% TAE gel stained with 0.5X SYBR Safe 
(Invitrogen, P/N S33102). 
 
Labeling 
 Up to 4 µg of extracted DNA was fragmented in a 20 µl reaction containing 
0.6U/µg DNaseI (Amersham Biosciences, P/N 27-0514-01) (diluted in 1X One-Phor-All 
Buffer), 2 µl 10X One-Phor-All Buffer (Amersham Biosciences, P/N 27-0901-02), and 
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up to 20 µl Nuclease-free water.  The reaction was incubated at 37°C for 10 minutes and 
inactivated at 98°C for 10 minutes.  A portion of the extracted DNA was examined on a 
1% TBE gel stained with 1X SYBR Gold (Molecular Probes, P/N S-11494). 
The entire fragmented DNA sample was labeled on the 3’ termini in a 50 µl 
reaction containing 2 µl of 7.5 mM GeneChip DNA Labeling Reagent (Affymetrix, P/N 
900542), 10 µl 5X Reaction Buffer, 2 µl Terminal Deoxynucleotidyl Transferase 
(Promega, P/N M1875), and up to 50 µl Nuclease-free water.  The reaction was incubated 
at 37°C for 1 hour and was stopped with 2 µl of 0.5 M EDTA.   
A gel-shift assay was run to verify labeling efficiency.  5 µl of 2 mg/mL 
ImmunoPure NeutrAvidin (Pierce Chemical, P/N 31000) was added to a 200 ng aliquot 
of labeled DNA and incubated at room temperature for 5 minutes.  DNA sample was 
loaded onto a 1% TBE gel, after which the gel was stained in 1X SYBR Gold for 10 
minutes. 
 
Hybridization, Washing, Scanning 
 The labeled DNA was diluted in 6.5 µl of 20X Hybridization controls and 
Nuclease-free water up to 50 µl.   Diluted labeled DNA/Hybridization control mix was 
added to a hybridization cocktail and hybridized to the STYLMONOa520430F GeneChip 
according to the Affymetrix Prokaryotic Target Hybridization protocol under the 100 
format (Midi).  The arrays were incubated at 45°C at 50 rpms for 16 hours in a GeneChip 
Hybridization Oven 640.  Arrays were washed and stained in a GeneChip Fluidics Station 
450 and scanned with a GeneChip Scanner 3000.  Washing, staining and scanning were 
done according to the Affymetrix Prokaryotic Arrays: Washing, Staining, and Scanning 
protocol.  
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Table 6. Primers Sequences that Target the 16S Gene of Each Pathogen 
Pathogen Primer Sequence 
P. multocida 
F - 5’-AACACATGCAAGTCGAACGG 
R - 5’-TGACGGGCGGTGTGTACAA 
M. haemolytica 
F - 5’-TCAGATTGAACGCTGGCGGC 
R - 5’-CACACCCCAGTCATGAATCATACCG 
H. somni 
F - 5’-GAGTGGCGGACGGGTGAGTAAA 
R - 5’-ACTTCTGGTACAACCCACTCCCATG 
A. pyogenes 
F - 5’-GCGTGCTTAACACATGCAAGTCG 
R - 5’-TCACCGCAGCGTTGCTGATC 
S. typhimurium 
F - 5’-GTTTGATCCTGGCTCAGATTGAACG 
R – 5’-CGGACTACGACGCACTTTATGAGGT 
S. dublin 
F - 5’-GTTTGATCCTGGCTCAGATTGAACG 
R - 5’-TCGCGAGGTCGCTTCTCTTTGT 
E. coli 
F - 5’-TTGATCATGGCTCAGATTGAACGC 
R - 5’-CTAGCGATTCCGACTTCATGGAGTC 
 
Data Analysis 
 The .cel files generated by the GeneChip Operating Software were processed in 
R.  Since the arrays did not have MM probes, background was corrected using the Robust 
Multi-Array (RMA) average expression method as it was designed to ignore MM signals.  
For the datasets that required normalization, we used the “constant” normalization 
method in which all of the arrays in a dataset were scaled to a chosen baseline array.  All 
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datasets were summarized using “pmonly,” which calculated a signal value for each 
probe set by averaging the individual probe signals (Appendix B).  
The arrays were analyzed by calculating a single signal value for each pathogen 
by averaging the probe set signal values.  This overall signal value was calculated for 
each pathogen on all arrays to see if any of the pathogen probe sets were showing 
positive signals on arrays for which the pathogen was not hybridized.  Background was 
also calculated for each array by averaging the probe set signal values for all non-target 
probe sets.  For the background value, a select number of probe sets were excluded from 
analysis: the hybridization controls, which produced strong positive signals, and probe 
sets representing the intergenic regions of L. monocytogenes and S. typhimurium.  These 
intergenic regions were excluded because they showed significant cross hybridization and 
produced strong signals that interfered with analysis.  Overall signal value for all 
pathogens was compared on each array with the average background signal to determine 
whether a pathogen was detected on an array.  Ideally, the target pathogen would show a 
signal higher than that of the calculated background.  Also, the signal values for the 
pathogens not targeted on an array would be equivalent to that of the background signal.  
  
Results 
 
GeneChip Validation 
 Three STYLMONOa520430F arrays were hybridized with unknown 
concentrations of P. multocida DNA.  The signal values for P. multocida were 224.39, 
2438.39, and 164.21 while the signal for background and other pathogens ranged from 
0.7 to 2.31 (figure 7).  The hybridized arrays were analyzed further by analyzing the 
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signal values of the individual probe sets that targeted the different P. multocida genes.  
Of the 56 different probe sets that targeted P. multocida, 46 consistently produce positive 
signals at various strengths.  However, 10 probe sets refused to produce any signal with 
all three hybridized arrays (figure 8, shows data from one array).  With PCR and primers 
designed to amplify those 10 genes represented by the failed probe sets, we determined 
that those specific gene sequences were not present in our P. multocida DNA samples.  
We also determined that the different probe sets did not respond equally, in that some 
probe sets produced stronger signals than other probe sets hybridized with the same DNA 
(figure 8).   
 
 
Figure 7. Validation of STYLMONOa520430F GeneChip using P. multocida. 
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Figure 8. Evaluation of P. multocida probe sets. 
 
 
Detection Limit 
 We used P. multocida in a series of detection limit experiments.  We hybridized 
P. multocida to the STYLMONOa520430F array with 1 µg, 500 ng, 250 ng, and 10 ng of 
DNA.  Each concentration only had 1 replicate except at 250 ng, which had 2 replicates.  
This dataset was normalized for comparison and as expected, we saw a decrease in signal 
value as we decreased the amount of DNA added to the array.  At DNA concentrations of 
1000, 500, and 250 ng, the signal value for the P. multocida genes (86.76, 49.75, and 
19.97, respectively) was much higher than the background signal (1.39, 1.38, and 1.53, 
respectively) (figure 9).  The 10 ng DNA concentration did not show a significantly 
higher signal at 1.68 than the background at 1.46.  To ensure good detection, remaining 
experiments were run at a DNA concentration of 250 ng or higher.   
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Figure 9. Detection limit of P. multocida. 
 
 
Probe Set and Cross Hybridization Evaluation  
To determine which genes gave positive signals for each bacterium and evaluate 
cross hybridization issues, M. haemolytica, H. somni, A. pyogenes, S. dublin, and E. coli 
were hybridized to individual STYLMONOa520430F arrays at 250 ng each.  Only field 
isolates of S. dublin were hybridized.  The P. multocida (250 ng) data from the previous 
experiment was added to this dataset.  DNA from bovine lung, liver, kidney, and spleen 
was also hybridized at 250 ng each on a single STYLMONOa520430F array, as a 
negative control and to confirm that DNA from bovine tissue would not cross hybridize 
to any of the genes on the array.  DNA from all bacterial species were hybridized in 
duplicates on separate days except S. dublin, which had only one replicate.  
 All arrays hybridized with P. multocida, A. pyogenes, and S. dublin showed 
positive signals for their target bacterial DNA when hybridized with 250 ng of DNA.  For 
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P. multocida, 46 of 56 genes continued to produce a positive signal.  In the two 250 ng 
arrays, the target probe sets produced signal values of 26.71 and 13.23 with a background 
of 1.60 and 1.47, respectively (figure 10).  Signal values for the other pathogens ranged 
from 1.20-2.39 on both arrays.  Genes designated PM_r01_at and PM_r02_at, which 
represent 16S and 23S genes, were among the positive signaling genes.   
The arrays hybridized with A. pyogenes DNA had 1 of 2 genes that showed a 
positive signal.  The two A. pyogenes arrays had target signal values of 7.75 and 4.6 with 
backgrounds of 1.28 and 1.48, respectively (figure 11).  The 16S gene designated 
AP_16S showed strong signals at 14.15 and 7.4 while the published hypothetical genes 
designated AP_smc_plo_ftsyY showed no signal at 1.36 and 1.8.  Signal values for the 
other bacteria ranged from 1.04 - 1.8 on both arrays.   
The single S. dublin-hybridized array had a target signal value of 9.39 with a 
background of 1.17 (figure 12).  S. dublin genes were the most successful of all the 
bacterial probe sets in terms of percentage.  Only one gene, SD_273, failed to produce a 
signal, while the remaining genes produced positive signals of various strengths.  
However, this was the only array to show significant cross hybridization with another 
pathogen, S. typhimurium, with a signal value of 5.55, which will be discussed later.  All 
other pathogen signal values ranged from 0.92-1.19. 
S. typhimurium DNA was hybridized to the arrays in a previous project.  No cross 
hybridization to any other bacterial DNA represented on the array was evident.75 
M. haemolytica and H. somni did not demonstrate any significant signal above the 
background at 250 ng.  The two M. haemolytica arrays had target signal values of 1.44 
and 1.31 with backgrounds of 1.39 and 1.32 (figure 13).  The other pathogenic signal 
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values ranged from 1.29-1.65.  H. somni signal values were barely detectable at 2.65 and 
2.17 with background values of 1.4 and 1.48.  Signal values for the other pathogens 
ranged from 1.23 to 1.56 (figure 14).  To determine if these genes were failing to 
hybridize or were simply below their detection limits, we also hybridized 1µg of M. 
haemolytica and H. somni DNA. With these increased concentrations, we saw a higher 
signal of 34.49 in M. haemolytica (figure 13).  However, this signal was only produced 
by one of the three genes designated MH_lpsA_at.  The remaining two genes, 
MH_16S_at and MH_lktA_at, still did not show positive signals with the increased DNA 
concentration.  H. somni hybridization responded in a similar fashion with the increase in 
hybridized DNA.  Gene designation HS_rpoB_at produced a stronger signal of 19.37 and 
gene designation HS_16S_at produced a moderate signal of 5.5 creating an average of 
12.44 (figure 14).  Ultimately, 250 ng of DNA was below the detection limit for these 
probe sets. 
We hybridized three different strains of E. coli to the array (O157 and field 
isolates 1 & 3).  Two E. coli O157 (1µg)-hybridized arrays produced overall signal 
values of 40.28 and 42.88 with backgrounds of 1.14 and 1.11 (figure 15).  Neither of the 
two field isolates (250 ng) showed strong average signals with values of 2.81 and 1.98 
with backgrounds of 1.38 and 1.79 (figure 15).  However, both isolates did hybridize to 
different individual probes sets.  Isolate 1 hybridized strongly to 4 out of 50 E. coli probe 
sets, and isolate 3, which was considered non-pathogenic and part of the normal flora of a 
cow’s rumen, showed some minor signal with approximately 5 out of 50 E. coli probe 
sets (data not shown).  If the 45-46 non-hybridized genes are not considered, and only the 
positive signals are averaged, signal values of 18.96 and 5.04 for isolates 1 and 3, 
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respectively, with backgrounds of 1.38 and 1.79 (figure 15) are recognized.  All other 
pathogenic signal values ranged from 1.08-2.3.  Furthermore, when E. coli probe set 
performance was evaluated with 1 µg of DNA from E. coli field isolates 1 & 2, we saw 
different hybridization patterns between to the two isolates.  We observed the same four 
genes showing strong signals with E. coli field isolate 1 DNA as was in previous 
experiments, only at higher levels with the increase in target DNA concentration, and five 
genes showing signal with field isolate 2.  Of the nine probe sets that successfully 
hybridized to target DNA, only two of probes sets hybridized with both field isolate 1 and 
2 (figure 16).  This demonstrates the limits of the designed microarray when hybridizing 
different strains of the same bacterial genus.   
DNA from bovine tissue (negative control) (lung, liver, spleen, and kidney) 
hybridized to two arrays did not show any significant binding with any of the bacterial 
genes (1.41-2.98 with backgrounds of 2.42 and 1.53) (figure 17). 
 Almost all cross hybridization occurred within the probe sets designed from the 
intergenic regions of S. typhimurium and L. monocytogenes.  Therefore, these regions 
were removed from data analysis.  Furthermore, cross hybridization was limited to 
random false positives that were not consistent in any of the repeated experiments.  For 
example, the S. typhimurium gene designated STM0417 showed a medium signal on one 
of the P. multocida arrays at 6.23, but only produced signal values that ranged from 1.26-
2.95 on the other seven P. multocida arrays.  One major exception to this pattern was 
found in the S. dublin array in which gDNA cross hybridized to a significant portion of 
the S. typhimurium genes of which less than 1% had a higher signal than the highest S. 
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dublin gene (23.44) and about 40% had a higher signal than the lowest S. dublin gene 
signal considered positive (4.46). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Detection of P. multocida. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Detection of A. pyogenes. 
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Figure 12. Detection of S. dublin. 
 
Figure 13. Detection of M. haemolytica. 
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Figure 14. Detection of H. somni. 
 
Figure 15. Detection of E. coli. 
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Figure 16. Hybridization Analysis of E. coli Probe Sets. 
 
Figure 17. Detection of Bovine DNA extracted from lung, liver, kidney, and spleen. 
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Detection of Pathogen-Spiked Tissue  
DNA extracted from lung, liver, kidney, and spleen, all of which were spiked with 
multiple bacterial species of confirmed identity (PCR), was hybridized individually to 
four STYLMONOa520430F arrays.  Field isolates of each pathogen were hybridized to 
the arrays.  The two exceptions were P. multocida (ATCC 12945), since we were unable 
to obtain a field isolate, and E. coli (O157), because we have already shown that different 
strains of E. coli do not hybridize to most of the E. coli probe sets.  The signal value for 
each pathogen was averaged across the arrays and multiple replicates.  The overall 
background for the arrays for comparison was 12.98.   Positive signals were seen with P. 
multocida (2062.08), H. somni  (1527.33), M. haemolytica (2274.99), A. pyogenes 
(152.78), S. dublin (1688.08), E. coli (2299.20) and S. typhimurium (2040.25) (figure 18, 
values transformed with squareroot to bring the extreme value differences closer together 
for easier comparison).  With increased concentrations of DNA hybridized to the arrays, 
some of the genes that were previously not producing signals, or were producing 
relatively weak signals, were now showing stronger signals.  We also observed signals 
produced by the genes designated HS_16S_at, AP_smc_plo_ftsY_at, and SD_273_at, 
where previously we saw no signal.  However, even though these probe sets were now 
showing hybridizing signals, they were still lower than their counterparts, further 
confirming that different probe sets for the same pathogen had different detection limits.  
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Figure 18. Detection of pathogens spiked into bovine tissue. 
 
 
Discussion 
 
 
 Microarrays have the potential for detection of multiple bacterial species in cases 
of mixed infections in a single assay.  Here we report on the design and evaluation of a 
simple DNA microarray used for the detection of pathogenic bacteria that commonly 
afflict cattle.  The prototype array was designed on an Affymetrix platform and contained 
4686 probe sets representing 7 bacterial pathogens (P. multocida, H. somni, M. 
haemolytica, and A. pyogenes, E. coli, S. typhimurium, and S. dublin) that commonly are 
isolated from bovines.  All of the genes selected for probe design were either selected 
from BLAST comparisons or through a review of the literature.  As such, each of the 
bacterial species has a different number of genes represented on the array, from S. 
typhimurium, represented by over 4500 genes, to H. somni and A. pyogenes, both with 
only two genes represented.   
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We have demonstrated the ability to detect P. multocida, A. pyogenes, S. dublin, 
and S. typhimurium with as little as 250 ng of target DNA.  We failed to detect M. 
haemolytica, H. somni, and E. coli at 250 ng, but were able to detect them at 1 µg and 
higher. 
We also found that different probe sets for each pathogen had their own detection 
limits.  For example, in one of the P. multocida microarrays, the signal for each of the 
positive probe sets ranged from 75.05 to 414.05.  Also, some of the probe sets, such as 
HS_16S_at, SD_273_at, and AP_smc_plo_ftsY_at, failed to produce signal at lower 
concentrations even though fellow probe sets which target the same bacterial DNA 
showed a strong signal.  However, as increased target DNA concentrations were 
hybridized, these seemingly “failed” probe sets were now successful in producing a 
signal, though always lower than their counterparts.  This data demonstrates that the 
probe sets performed at different limits of detection.   
Despite increases in hybridized target DNA, some probe sets, notably the 10 P. 
multocida and 2 M. haemolytica genes, failed to ever produce a signal.  PCR confirmed 
that most of these exact sequences were not found in the genomes of the strains used in 
this study.  Exceptions include probe sets that targeted the 16S gene, indicating that a few 
of the probe sets may not have been universally representative for the species of 
bacterium they targeted. 
We demonstrated that the probe sets were robust and able to target multiple 
strains by successfully hybridizing and detecting at least two different strains for most of 
the bacterial pathogens.  Since two strains was the limit for most of the bacteria, further 
tests using more strains are needed to confirm this.  Exceptions were P. multocida (only 
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one strain available) and E. coli.  Since E. coli probe sets were designed from the O157 
genome, we were not surprised when we saw strong signals when hybridized with O157 
DNA.  However, we were unable to see the same signal strength when we hybridized two 
other pathogenic E. coli strains.  Instead, only 4-5 genes sufficiently complimented the 
probe sets to produce positive signals, and each strain produced a different hybridization 
pattern. 
Finally, we were able to show that we could detect bacterial DNA in tissue spiked 
with mixed cultures.  In experiments in which DNA, extracted from bovine lung, liver, 
kidney, and spleen spiked with mixed cultures of pathogenic bacteria, was hybridized to 
individual arrays, the arrays correctly detected and identified each bacterial pathogen.  It 
is interesting to note that the average detection signals for each of the spiked bacterial 
pathogens were close at values of around 2000.  However, A. pyogenes produced a value 
of about 150 which is likely due to the fact that it was the only Gram + species in the 
group, and may have experienced inefficient cell wall lysis.  A change in the DNA 
extraction protocol that would be more suited towards Gram + species would confirm 
this. 
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CHAPTER IV  
SUMMARY 
 
 Microarray technology has a huge potential in veterinarian diagnostic 
applications.  Currently, there are a multitude of different diagnostic tests used to identify 
specific pathogens.  These tests can be collectively expensive and time consuming to 
perform.  Most of the tests require extensive handling of potentially zoonotic agents 
requiring the need of BSL facilities, equipment, and proper training for safety reasons.  
The diagnostics test designed here can detect and correctly identify the presence of 
pathogenic bacteria using microarray technology by extracting bacterial DNA directly 
from spiked tissue and hybridizing the mixed sample to our array.  Though microarrays 
can be individually expensive, an all-in-one diagnostic test is potentially less expensive 
than running multiple tests that may be required for diagnosis of mixed infections.  
In the designing of our microarrays, our primary goal was to design an array that 
could correctly identify bovine pathogens from single and multiple infections.  Our 
secondary objective was to design an array that would not only be relatively inexpensive 
to current standard microarray costs, but also be comparable to the costs of current 
veterinarian diagnostic techniques, especially considering multiple tests would be 
required to diagnose a multi-organ infections.   
 Our first array, the in-house platform, was designed and built as a cost-effective 
microarray using in-house equipment and relatively cheap material that could identify 
four respiratory pathogens (P. multocida, H. somni, M. haemolytica, A. pyogenes) that 
commonly afflict cattle by targeting the 16S gene.  The microarray array produced a 
specific, easy-to-see, hybridization pattern that was unique to each of the four pathogens 
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without the need for complicated analytical software.  However, the biggest flaw in the 
design was the need to first PCR-amplify the target DNA (16S gene) prior to 
hybridization.  Ultimately, with the technology available to us, we were unable to spot 
the probes with sufficient concentration to allow detection of the target DNA without 
prior amplification.  One option to overcome this obstacle would be to design a set of 
primers that would amplify the 16S gene of all the pathogens of interest in the same 
reaction.  However, we were more interested in showing that we could detect the 
pathogen DNA from an infection without the need for amplification.   
The second array was designed by partnering with Affymetrix, who had the 
ability to create an array with a much higher probe concentration (as much as 1,000,000 
probes/cm2).  This custom array, which targeted multiple genes for seven bovine 
pathogens (the previous four plus E. coli, S. typhimurium, S. dublin), was able to detect 
all of the pathogens by hybridizing unamplified chromosomal DNA.  Some of the 
pathogens were detectable with as little as 250ng of DNA hybridized, while others 
required at least 1ug.  Also, we were able to successfully detect each pathogen from a 
simulated multi-organ infection.  The major drawback to the Affymetrix arrays is the cost 
associated with each experiment.  Indiviually, the GeneChips are more expensive than the 
conventional in-house arrays.  Also, specific and expensive equipment is also necessary 
to process GeneChip arrays.  Nevertheless, despite the added cost, the Affymetrix 
platform is still be comparable to the cost of multiple diagnostics tests looking for 
multiple infections.   
Both microarray designs have advantages and disadvantages when compared with 
each other.  The Affymetrix arrays successfully detected each pathogen in simulated 
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single and multiple infections without first requiring PCR-amplification of the target 
genes.  However, our in-house arrays were able to produce a visible hybridization pattern 
without the need for software analysis, and the arrays were much cheaper, both in 
constructing and processing the arrays, than their Affymetrix counterparts.  
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APPENDIX A - Genes represented on the STYLMONOa520430F GeneChip 
 
Probe Set Designation  Gene Function 
Controls     
AFFX-BioB-3_at   Affymetrix Hybridization Control  
AFFX-BioB-5_at   Affymetrix Hybridization Control 
AFFX-BioB-M_at   Affymetrix Hybridization Control   
AFFX-BioC-3_at   Affymetrix Hybridization Control 
AFFX-BioC-5_at   Affymetrix Hybridization Control 
AFFX-BioDn-3_at   Affymetrix Hybridization Control 
AFFX-BioDn-5_at   Affymetrix Hybridization Control 
AFFX-CreX-3_at   Affymetrix Hybridization Control 
AFFX-CreX-5_at   Affymetrix Hybridization Control 
AFFX-r2-Ec-bioB-3_at  Affymetrix Hybridization Control 
AFFX-r2-Ec-bioB-5_at  Affymetrix Hybridization Control 
AFFX-r2-Ec-bioB-M_at  Affymetrix Hybridization Control 
AFFX-r2-Ec-bioC-3_at  Affymetrix Hybridization Control 
AFFX-r2-Ec-bioC-5_at  Affymetrix Hybridization Control 
AFFX-r2-Ec-bioD-3_at  Affymetrix Hybridization Control 
AFFX-r2-Ec-bioD-5_at  Affymetrix Hybridization Control 
AFFX-r2-P1-cre-3_at   Affymetrix Hybridization Control 
AFFX-r2-P1-cre-5_at   Affymetrix Hybridization Control 
 
A. pyogenes 
AP_16S_at    16S ribosomal RNA 
AP_smc_plo_ftsY_at chromosome segregation protein (smc) gene, 
hypothetical protein, pyolysin (plo),  
signal recognition particle receptor (ftsY) 
 
H. somni 
HS_16S_at    16S ribosomal RNA 
HS_rpoB_at    rpoB gene 
 
M. haemolytica 
MH_16S_at    16S ribosomal RNA 
MH_lktA_at    lktA leukotoxin 
MH_lpsA_at    glycosyltransferase LpsA 
 
P. multocida 
PM_r01_at    16S ribosomal RNA 
PM_r02_at    23S ribosomal RNA 
All other probe sets   hypothetical proteins 
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Probe Set Designation  Gene Function 
S. dublin 
All probe sets    hypothetical proteins 
 
E. coli 
Z0146_RC_at    yadC putative fimbrial protein 
Z0213_x_at    rrsH 16S ribosomal RNA 
Z0219_at    rrlH 23S ribosomal RNA 
Z0334_RC_at sidI putative capsid morphogenesis protein encoded 
in CP-933I 
Z0967_at    putative protease encoded in prophage CP-933K 
Z1370_at putative tail component encoded by cryptic 
prophage CP-933M 
Z1385_RC_at putative secreted protein encoded by cryptic 
prophage CP-933M 
Z1797_at    putative antirepressor of prophage CP-933N 
Z1818_at putative antirepressor protein encoded by prophage 
CP-933N 
Z3622_at    putative resolvase 
Z3783_RC_at    putative dimethyl sulfoxide reductase subunit C 
All other probe sets   hypothetical proteins 
 
S. typhimurium 
All genes from chromosome and plasmid are represented 
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APPENDIX B - R Code Used to Analyze Affymetix Arrays 
 
library(affy) # For affy files 
#memory.limit(size=4000) # Increase memory use 
 
# Load in library files 
library(makecdfenv) 
 
#Choose Mac or Windows, not both. 
 
#Mac 
STYLMONOa520430F = make.cdf.env("STYLMONOa520430F.cdf") 
 
#Windows 
make.cdf.package("STYLMONOa520430F.cdf", species="Bovine_Pathogens") 
 
# Read in .cel files from laptop 
data = ReadAffy(celfile.path="//Users//Ryan//Desktop//RB1-30") 
 
# RMA normalization and avg PM values for each chip 
eset = expresso(data[1,30], bgcorrect.method = "rma", normalize.method = "constant", 
pmcorrect.method = "pmonly", summary.method = "avgdiff") 
 
# write the eset file to an excel spreadsheet 
library(marray) 
 
write.xls(eset, file = "Data.xls") 
 
# Organize the data; create multiple files; 1 with positive probes; 1 with all background 
noise; save them as .csv files 
 
# Write subset probes to object 
PM.sig.values = read.csv("C:\\Documents and Settings\\Ryan\\Desktop\\Data.pm.csv") 
bg.sig.values = read.csv("C:\\Documents and Settings\\Ryan\\Desktop\\Data.bg.csv")  
 
 
